Market Overview

Dova Pharmacueticals Updates ITP and CIT Programs Following FDA Mtgs.; Will Submit sNDA For ITP 2H18, Phase 3 Trial For CIT To Begin Q2

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Biotech News FDA Events Trading Ideas

 

Related Articles (DOVA)